TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay July 17, 2009
TCL Archive Society Growth continues, With OS The Largest; ASCO Plans to Reduce flow Of Medical Oncologists; AACR To Impose Page Charges for “Cancer Research: May 31, 1985